Literature DB >> 31578557

Right ventricular strain rate during exercise accurately identifies male athletes with right ventricular arrhythmias.

Mathias Claeys1,2, Guido Claessen1,2,3, Piet Claus1, Ruben De Bosscher1,2, Christoph Dausin4, Jens-Uwe Voigt1,2, Rik Willems1,2, Hein Heidbuchel5, Andre La Gerche1,3.   

Abstract

AIMS: Athletes with right ventricular (RV) arrhythmias, even in the absence of desmosomal mutations, may have subtle RV abnormalities which can be unmasked by deformation imaging. As exercise places a disproportionate stress on the right ventricle, evaluation of cardiac function and deformation during exercise might improve diagnostic performance. METHODS AND
RESULTS: We performed bicycle stress echocardiography in 17 apparently healthy endurance athletes (EAs), 12 non-athletic controls (NAs), and 17 athletes with RV arrhythmias without desmosomal mutations (EI-ARVCs) and compared biventricular function at rest and during low (25% of upright peak power) and moderate intensity (60%). At rest, we observed no differences in left ventricular (LV) or RV function between groups. During exercise, however, the increase in RV fractional area change (RVFAC), RV free wall strain (RVFWSL), and strain rate (RVFWSRL) were significantly attenuated in EI-ARVCs as compared to EAs and NAs. At moderate exercise intensity, EI-ARVCs had a lower RVFAC, RVFWSL, and RVFWSRL (all P < 0.01) compared to the control groups. Exercise-related increases in LV ejection fraction, strain, and strain rate were also attenuated in EI-ARVCs (P < 0.05 for interaction). Exercise but not resting parameters identified EI-ARVCs and RVFWSRL with a cut-off value of >-2.35 at moderate exercise intensity had the greatest accuracy to detect EI-ARVCs (area under the curve 0.95).
CONCLUSION: Exercise deformation imaging holds promise as a non-invasive diagnostic tool to identify intrinsic RV dysfunction concealed at rest. Strain rate appears to be the most accurate parameter and should be incorporated in future, prospective studies to identify subclinical disease in an early stage. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  ARVC; deformation imaging; right ventricle; sports cardiology; stress echocardiography

Mesh:

Year:  2020        PMID: 31578557     DOI: 10.1093/ehjci/jez228

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  4 in total

Review 1.  Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19: An Expert Consensus Statement.

Authors:  Dermot Phelan; Jonathan H Kim; Michael D Elliott; Meagan M Wasfy; Paul Cremer; Amer M Johri; Michael S Emery; Partho P Sengupta; Sanjay Sharma; Matthew W Martinez; Andre La Gerche
Journal:  JACC Cardiovasc Imaging       Date:  2020-10-28

2.  Analysis of Regional Right Ventricular Function by Tissue Doppler Imaging and Three-Dimensional Echocardiography in Highly Trained Athletes.

Authors:  Maria Vincenza Polito; Rodolfo Citro; Gennaro Galasso; Andreas Hagendorff
Journal:  J Cardiovasc Echogr       Date:  2020-11-09

3.  Rationale and design of the PROspective ATHletic Heart (Pro@Heart) study: long-term assessment of the determinants of cardiac remodelling and its clinical consequences in endurance athletes.

Authors:  Ruben De Bosscher; Christophe Dausin; Kristel Janssens; Jan Bogaert; Adrian Elliott; Olivier Ghekiere; Caroline M Van De Heyning; Prashanthan Sanders; Jonathan Kalman; Diane Fatkin; Lieven Herbots; Rik Willems; Hein Heidbuchel; André La Gerche; Guido Claessen
Journal:  BMJ Open Sport Exerc Med       Date:  2022-03-18

4.  A randomized controlled trial of enhancing hypoxia-mediated right cardiac mechanics and reducing afterload after high intensity interval training in sedentary men.

Authors:  Yu-Chieh Huang; Chih-Chin Hsu; Tieh-Cheng Fu; Jong-Shyan Wang
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.